Together we will defeat dementia

Free Bristol Event: Let's Talk Dementia 2026

You are invited to Let’s Talk Dementia, a free public information event on Saturday 23rd May, 10.30 am - 4.30 pm, at the Bristol Beacon. LTD is a one-stop shop for all things dementia.

Leave a Gift in your Will for dementia research

Gifts in Wills make long-term research and pioneering trials possible, leading to earlier diagnosis, better and more effective treatments, and one day a cure.

Race for BRACE in 2026 #TeamBRACE

Looking to get fit in 2026 and support dementia research at the same time? We have a wide range of events for you, from 10k races to full marathons in the UK and abroad.

BRACE Autumn - Winter Magazine

The magazine is filled with the latest research news, events and inspiring stories. Learn about the less well known symptoms of dementia, research on early diagnosis and more...

Remember and pay tribute to your loved ones

There are many ways you can commemorate your loved ones, from setting up a free tribute page, to donating or adding their name to the Book of Remembrance.

A dementia diagnosis from home?

Dr George Stothart shares his early dementia test - Fastball - results. His research shows the test can be used at home to detect memory decline in people with MCI.

We Believe In a World Free From Dementia

Every donation, no matter the size, helps BRACE fund vital research that creates scientific progress and real hope for the future - earlier diagnosis, more effective treatments and, one day, a cure. Thank you for your support.

Together we will defeat dementia

Latest news

£100k awarded to Swansea researchers developing gut hormone dementia treatment 

BRACE has awarded Swansea University researchers £102,949 to investigate a stomach hormone’s role in a potential new dementia treatment.  The funding has been awarded to Prof Jeff Davies and will be used to support a PhD student who will work alongside Prof Davies to conduct laboratory research into ghrelin, a stomach hormone best known for…

A second chance for the NHS to use early Alzheimer’s drugs?

The National Institute for Health and Care Excellence (NICE) will review, for a second time, NHS use of the early Alzheimer’s drugs, lecanemab and donanemab. The breakthrough drugs, which are the first in the world to be disease-modifying, were rejected for NHS patient use due to the high cost, in 2025. However, they have been…

Events

No event found!